{"organizations": [], "uuid": "666f11347e2a6a2eb9825b8f9e27c5e7a1983efb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-soligenix-receives-orphan-drug-des/brief-soligenix-receives-orphan-drug-designation-from-the-european-commission-for-rivax-for-prevention-of-ricin-poisoning-idUSFWN1R40E7", "country": "US", "domain_rank": 408, "title": "BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T12:18:00.000+02:00", "replies_count": 0, "uuid": "666f11347e2a6a2eb9825b8f9e27c5e7a1983efb"}, "author": "", "url": "https://www.reuters.com/article/brief-soligenix-receives-orphan-drug-des/brief-soligenix-receives-orphan-drug-designation-from-the-european-commission-for-rivax-for-prevention-of-ricin-poisoning-idUSFWN1R40E7", "ord_in_thread": 0, "title": "BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "european commission for rivax for prevention", "sentiment": "negative"}, {"name": "european commission for rivax for prevention of ricin poisoning reuters", "sentiment": "none"}, {"name": "soligenix inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 22, 2018 / 10:19 AM / Updated 17 minutes ago BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning Reuters Staff 1 Min Read March 22 (Reuters) - Soligenix Inc: * SOLIGENIX RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN COMMISSION FOR RIVAXÂ® FOR PREVENTION OF RICIN POISONING Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-22T12:18:00.000+02:00", "crawled": "2018-03-22T12:39:06.005+02:00", "highlightTitle": ""}